John M. Sparrow

John M. Sparrow

Auto-generated profile, based on publicly available information

John M. Sparrow

Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2012 in Eye
Verified
Journal Article
Closed access
TGthe UK EPR user group
the UK EPR user group
JSJ M Sparrow
J M Sparrow
HTH Taylor
H Taylor
KQK Qureshi
K Qureshi
RSR Smith
R Smith
RJR L Johnston
R L Johnston

24 August 2022 in Eye
Verified
Journal Article
Closed access
PDF file
PDPaul H. J. Donachie
Paul H. J. Donachie
BBBeth L. Barnes
Beth L. Barnes
MOMartina Olaitan
Martina Olaitan
JSJohn M. Sparrow
John M. Sparrow
JBJohn C. Buchan
John C. Buchan

26 January 2018 in Eye
Verified
Journal Article
Open access
PDF file
JSJ M Sparrow
J M Sparrow
MGM T Grzeda
M T Grzeda
NFN A Frost
N A Frost
RJR L Johnston
R L Johnston
CLC S C Liu
C S C Liu
JDJ L Donovan
J L Donovan
Background Cataract surgery is the most frequently undertaken NHS surgical procedure. Visual acuity (VA) provides a poor indication of visual difficulty in a complex visual world. In the absence of a suitable outcome metric, recent efforts have been directed towards the development of a cataract patient-reported outcome measure (PROM) of sufficient brevity, precision, and responsiveness to be implementable in routine high volume clinical services. Aim To compare and contrast the two most promising candidate PROMs for routine cataract surgery. Method The psychometric performance and patient acceptability of the recently UK developed five-item Cat-PROM5 questionnaire was compared with the English translation of the Swedish nine-item Catquest-9SF using Rasch-based performance metrics and qualitative semistructured interviews. Results Rasch-based performance was assessed in 822 typical NHS cataract surgery patients across four centres in England. Both questionnaires demonstrated good to excellent performance for all metrics assessed, including Person Reliability Indices of 0.90 (Cat-PROM5) and 0.88 (Catquest-9SF), responsiveness to surgery (Cohen’s standardized effect size) of 1.45 SD (Cat-PROM5) and 1.47 SD (Catquest-9SF) and they were highly correlated with each other (R=0.85). Qualitative assessments confirmed that both questionnaires were acceptable to patients, including in the presence of ocular comorbidities. Preferences were expressed for the shorter Cat-PROM5, which allowed patients to map their own issues to the questions as opposed to the more restrictive specific scenarios of Catquest-9SF. Conclusion The recently UK developed Cat-PROM5 cataract surgery questionnaire is shorter, with performance and patient acceptability at least as good or better than the previous ‘best of class’ Catquest-9SF instrument.

9 March 2018 in Eye
Verified
Journal Article
Open access
PDF file
JSJ M Sparrow
J M Sparrow
MGM T Grzeda
M T Grzeda
NFN A Frost
N A Frost
RJR L Johnston
R L Johnston
CLC S C Liu
C S C Liu
JDJ L Donovan
J L Donovan
Purpose To develop a short, psychometrically robust and responsive cataract patient reported outcome measure suitable for use in high-volume surgical environments. Methods A prospective study in which participants completed development versions of questionnaires exploring the quality of their eyesight using items harvested from two existing United Kingdom developed parent questionnaires. Participants were 822 patients awaiting cataract surgery recruited from 4 cataract surgical centres based in the UK. Exclusion criteria were other visually significant comorbidities and age <50 years. An iterative multi-stage process of evaluation using Rasch and factor analyses with sequential item reduction was undertaken. Results A definitive item set of just five items delivered performance in accordance with the requirements of the Rasch model: no threshold disordering, no misfitting items, Rasch-based reliability 0.90, person separation 2.98, Cronbach’s α 0.89, good targeting of questions to patients with cataract with pre-operative item mean −0.41 logits and absence of significant floor or ceiling effects, minor deviations of item invariance, and confirmed unidimensionality. The test–re-test repeatability intra-class correlation coefficient was 0.89 with excellent responsiveness to surgery, Cohen’s d −1.45 SD. Rasch calibration values are provided for Cat-PROM5 users. Conclusions A psychometrically robust and highly responsive five-item cataract surgery patient reported outcome measure has been developed, which is suitable for use in high-volume cataract surgical services.

6 May 2011 in Eye
Verified
Journal Article
Closed access
TGthe UK EPR user group
the UK EPR user group
JSJ M Sparrow
J M Sparrow
HTH Taylor
H Taylor
KQK Qureshi
K Qureshi
RSR Smith
R Smith
RJR L Johnston
R L Johnston

1 January 1998 in Eye
Verified
Journal Article
Open access
CBC C Bailey
C C Bailey
JSJ M Sparrow
J M Sparrow
RGR H B Grey
R H B Grey
HCH Cheng
H Cheng
The National Diabetic Retinopathy Laser Treatment Audit is a prospective survey of laser treatment for diabetic retinopathy throughout the United Kingdom. This paper describes the methodology of the study and presents data on 546 patients who were undergoing their first photocoagulation treatment for diabetic maculopathy (without proliferative retinopathy) during a 2 month period in 1995. Validation of the level of participation, patient demographic features, sources of referral, the level of systematic screening and waiting times are described. Maculopathy was detected as a result of systematic screening in 65.2%, whilst 12.3% of cases presented symptomatically. The percentage of cases treated within 8 weeks of listing was 83.1%, whilst 7% waited for more than 12 weeks for their laser treatment. The retinopathy features and the type of treatment given are also described. The maculopathy was said to be predominantly exudative in nature in 69.8% of cases, and 96.2% of these eyes were treated with focal macular laser. The maculopathy was said to be diffusely oedematous in nature in 8.6% of cases, and 78.7% of these eyes were treated with grid macular laser.